###begin article-title 0
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 66 80 66 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 66 80 <span type="species:ncbi:8355">Xenopus laevis</span>
The roles of Bcl-xL in modulating apoptosis during development of Xenopus laevis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 437 439 437 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 491 506 491 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR11 </italic>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 491 505 <span type="species:ncbi:8355">Xenopus laevis</span>
Apoptosis is a common and essential aspect of development. It is particularly prevalent in the central nervous system and during remodelling processes such as formation of the digits and in amphibian metamorphosis. Apoptosis, which is dependent upon a balance between pro- and anti-apoptotic factors, also enables the embryo to rid itself of cells damaged by gamma irradiation. In this study, the roles of the anti-apoptotic factor Bcl-xL in protecting cells from apoptosis were examined in Xenopus laevis embryos using transgenesis to overexpress the XR11 gene, which encodes Bcl-xL. The effects on developmental, thyroid hormone-induced and gamma-radiation-induced apoptosis in embryos were examined in these transgenic animals.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR11 </italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR11 </italic>
###xml 367 369 367 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 621 623 617 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 636 641 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR11 </italic>
Apoptosis was abrogated in XR11 transgenic embryos. However, the transgene did not prevent the apoptotic response of tadpoles to thyroid hormone during metamorphosis. Post-metamorphic XR11 frogs were reared to sexual maturity, thus allowing us to produce second-generation embryos and enabling us to distinguish between the maternal and zygotic contributions of Bcl-xL to the gamma-radiation apoptotic response. Wild-type embryos irradiated before the mid-blastula transition (MBT) underwent normal cell division until reaching the MBT, after which they underwent massive, catastrophic apoptosis. Over-expression of Bcl-xL derived from XR11 females, but not males, provided partial protection from apoptosis. Maternal expression of XR11 was also sufficient to abrogate apoptosis triggered by post-MBT gamma-radiation. Tolerance to post-MBT gamma-radiation from zygotically-derived XR11 was acquired gradually after the MBT in spite of abundant XR11 protein synthesis.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bcl-x</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 343 344 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L</italic></sub>
###xml 689 691 685 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Our data suggest that Bcl-xL is an effective counterbalance to proapoptotic factors during embryonic development but has no apparent effect on the thyroid hormone-induced apoptosis that occurs during metamorphosis. Furthermore, post-MBT apoptosis triggered by irradiation before the MBT could only be restrained by maternal expression of Bcl-xL. Although maternal expression of XR11 was sufficient to abrogate apoptosis triggered by post-MBT gamma-radiation, radiation tolerance from zygotically-derived XR11 was acquired gradually, indicating that synthesis of XR11 protein is not sufficient to prevent apoptosis. Thus, repression of radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing of its expression and post-translational events that enable the protein to become effective.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 842 843 842 843 <underline xmlns:xlink="http://www.w3.org/1999/xlink">T</underline>
###xml 856 857 856 857 <underline xmlns:xlink="http://www.w3.org/1999/xlink">U</underline>
###xml 860 861 860 861 <underline xmlns:xlink="http://www.w3.org/1999/xlink">n</underline>
###xml 865 866 865 866 <underline xmlns:xlink="http://www.w3.org/1999/xlink">e</underline>
###xml 869 870 869 870 <underline xmlns:xlink="http://www.w3.org/1999/xlink">l</underline>
###xml 933 941 933 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Cell death is an essential and integral aspect of embryonic development (for reviews, see [1-3]). The genome is programmed to eliminate certain cells or groups of cells at particular times during development by a process called "programmed cell death" (PCD) [4-6]. Well-known examples of PCD during vertebrate development include interdigital cell death and regression of the tail and gills during amphibian metamorphosis [3]. Considerable PCD also occurs in the central nervous system (CNS; for review, see [7]), where as much as 85% of some neuronal populations may be lost by PCD during development [8-11]. One form of PCD is apoptosis, which is characterized by membrane blebbing, nuclear and cytoplasmic shrinkage, chromatin condensation and DNA fragmentation [12]. The detection of DNA fragmentation in dying cells utilizing the TUNEL (TdT-mediated dUTP nick end labeling) assay provides the basis for a sensitive and specific in situ measure of apoptosis.
###end p 9
###begin p 10
###xml 9 24 9 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 181 189 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 729 737 729 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 9 23 <span type="species:ncbi:8355">Xenopus laevis</span>
The frog Xenopus laevis provides an excellent model system for studying apoptosis during embryonic development. The TUNEL assay has been used on whole-mounts and tissue sections of Xenopus embryos to monitor spontaneous developmental apoptosis [13,14]. Apoptosis also provides the means for the embryo to rid itself of cells damaged by DNA-damaging agents, such as gamma radiation [15]. Gamma radiation during embryonic development is a threat to the viability of the embryo and to its potential to develop into a healthy, functional adult organism. Embryos have two alternative mechanisms to prevent developmental abnormalities caused by irradiation: elimination of damaged cells through apoptosis or repair of the damaged DNA. Xenopus embryos undergo a dramatic transition in their response to ionizing radiation coincident with the onset of gastrulation. Embryos irradiated before gastrulation continue to cleave normally and undergo an abrupt, catastrophic, comprehensive and synchronous apoptosis of DNA-damaged cells after the mid-blastula transition (MBT) using a maternally-derived mechanism that does not require transcription [15-20]. In contrast, cells in embryos irradiated after gastrulation reportedly do not undergo apoptosis [17,19,20].
###end p 10
###begin p 11
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 787 788 787 788 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-2 </italic>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-x</italic>
###xml 955 957 955 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 955 957 955 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L </italic></sub>
###xml 1060 1062 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1104 1113 1104 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1117 1125 1117 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1152 1154 1152 1154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1162 1173 1162 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sufficient </italic>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1287 1296 1287 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1423 1429 1423 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-2 </italic>
###xml 1473 1482 1473 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1483 1485 1483 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1486 1488 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1522 1528 1522 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-2 </italic>
###xml 1603 1612 1599 1608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1616 1624 1612 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1625 1627 1621 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1628 1630 1624 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
###xml 1263 1268 <span type="species:ncbi:9031">chick</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
The induction of apoptosis is subject to both pro- and anti-apoptotic cellular factors and is executed by cysteine proteases called caspases after their activation from the proenzyme state. The activation of caspases can be triggered by cytochrome c release from the intermembrane spaces of mitochondria through mitochondrial outer membrane permeabilization [21-24]. Release of cytochrome c, in turn, is regulated by members of the Bcl-2 family (for reviews, see [23,25,26]). Members of the Bcl-2 family serve a key regulatory role in apoptosis, acting as either pro- or anti-apoptotic factors. Thus, the relative levels of members with opposing functions can determine whether cells live or die [27] (for review, see [26]). One of the anti-apoptotic members of the Bcl-2 family is Bcl-xL, which functions to inhibit apoptosis in situations in which Bcl-2 does not suffice [28]. For example, bcl-2 knockout mice are viable as embryos [29,30] whereas bcl-xL knockout mice die as embryos that exhibit massive cell death in the nervous and hematopoietic systems [31]. Over-expression studies conducted both in vitro and in vivo in mice indicate that Bcl-xL is also sufficient to promote survival of embryonic neurons [32-34]. Similar results have been obtained with chick embryonic neurons in vitro [35]. Members of the Bcl family also modulate the apoptogenic effects of DNA-damaging agents. For example, lymphoid cells from bcl-2 null mice are hypersensitive to irradiation in vitro [29,30]. Conversely, over-expression of bcl-2 reduces the rate of apoptosis of gamma-irradiated hematopoietic cells both in vitro and in vivo [36,37].
###end p 11
###begin p 12
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-</italic>
###xml 56 70 56 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR1 </italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XR11</italic>
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 482 490 482 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 598 613 598 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 874 881 874 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1153 1161 1153 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 56 70 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 312 315 <span type="species:ncbi:10116">Rat</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 598 612 <span type="species:ncbi:8355">Xenopus laevis</span>
Cruz-Reyes and Tata [38]cloned two bcl-related genes in Xenopus laevis, which they designated as XR1 and XR11. XR11 [GenBank:], which most closely resembles Bcl-xL, is expressed as early as stage 12 (gastrula) and continues to be expressed throughout embryonic, larval and adult life. Over-expression of XR11 in Rat-1 fibroblasts protected the cells from apoptosis, thus demonstrating that XR11 is an anti-apoptotic member of the Bcl family. Misexpression of human Bcl-2 or XR11 in Xenopus embryos has been shown to impede developmental- or chemically-induced apoptosis, respectively, during early Xenopus laevis embryonic development [17,39]. The transgenesis technique developed by Kroll and Amaya [40] provides the means to study the effects of genes on later developmental events and to examine the effects of the transgenes on subsequent generations. For example, Coen et al. [41] employed a neuron-specific promoter driving XR11 over-expression to demonstrate selective protection of Rohon-Beard cells during metamorphosis. In this report, we have used a constitutive promoter to examine the effects of generalized XR11 over-expression throughout Xenopus development and to examine the respective roles of maternal and zygotic XR11 in protection against gamma-radiation-induced apoptosis during development.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Over-expression of XR11 dramatically reduced spontaneous developmental apoptosis in embryos
###end title 14
###begin p 15
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 743 751 743 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 823 828 823 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A, C</xref>
###xml 947 952 947 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B, D</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1529 1530 1529 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 136 139 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Over-expression of XR11 in nuclear transplant embryos was achieved by utilizing a plasmid containing colinear CMVXR11 and CARGFP genes. CMV is a strong constitutive promoter in Xenopus, whereas XCAR promotes gene expression in muscle and cardiac tissue. Thus, XR11 should be expressed universally, whereas expression of the colinear GFP reporter gene in muscle and heart was used to select XR11 transgenics. To determine whether the over-expression of XR11 protected embryonic cells from apoptosis, we compared the incidence of TUNEL-positive nuclei between XR11 and control transgenic whole-mount and sectioned tailbud-stage embryos. Yeo and Gautier [39] demonstrated that the TUNEL assay is effective and specific for detecting apoptosis in Xenopus embryos. Examination of control whole-mount tailbud-stage embryos (Fig. 1A, C) showed that darkly labelled apoptotic nuclei are particularly prevalent in the heads, whereas XR11 transgenics (Fig. 1B, D) exhibited little or no detectable apoptosis. Examination of cross-sections (Fig. 2A) revealed that TUNEL-positive nuclei were most prevalent in the retinas and brains, whereas XR11 transgenic embryos lack TUNEL-positive nuclei. Counts of total TUNEL-positive nuclei in sections were made at stages 28, 33/34, 37 and 41 (Fig. 2B). In GFP controls, TUNEL-positive cells peaked at stage 33/34, whereas XR11 overexpressing embryos had nominal numbers of TUNEL-positive nuclei at all stages. For example, over-expression of XR11 at stage 33/34 reduced apoptosis by 95%. Student's t-tests indicate that the differences in the numbers of TUNEL-positive nuclei between the XR11 and GFP embryos are highly significant (p = 0.001 for stage 41 and 0.001 > p > 0.000 for stages 28, 33/34 and 37).
###end p 15
###begin p 16
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TUNEL assays on whole-mount tailbud-stage embryos at stages 28(<italic>A</italic>, <italic>B</italic>) and 33/34 (<italic>C</italic>, <italic>D</italic>)</bold>
TUNEL assays on whole-mount tailbud-stage embryos at stages 28(A, B) and 33/34 (C, D). A, C: GFP transgenic embryos B, D: XR11 transgenic embryos.
###end p 16
###begin p 17
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparisons of TUNEL-positive nuclei between GFP and XR11 transgenic embryos during embryonic development</bold>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left</italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 385 386 385 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
Comparisons of TUNEL-positive nuclei between GFP and XR11 transgenic embryos during embryonic development. A. Cross-sections of embryos showing the distribution of TUNEL-positive nuclei at the level of the eye at stage 33. DAPI (blue) and TUNEL (red) images have been superimposed. Left: GFP transgenic embryo. R, retina; B, brain. Right: XR11 transgenic embryo. Dorsal is at the top. B. Mean numbers of TUNEL-positive nuclei in sections at stages 28, 33/34, 37/38 and 41. Error bars indicate standard error of the mean. Means were obtained by examining between 14 and 18 embryos for each category. A minimum of 4 and a maximum of 14 sections were examined for each embryo. Pooled data from multiple experiments.
###end p 17
###begin title 18
Over-expression of XR11 did not impede apoptosis that occurs during normal or thyroid hormone-induced metamorphosis
###end title 18
###begin p 19
###xml 349 354 349 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, B</xref>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
If pro-apoptotic factors facilitate apoptosis during metamorphosis of tadpoles into frogs, we would expect over-expression of the anti-apoptotic XR11 to impede metamorphosis. However, XR11 transgenic tadpoles developed as apparently normal larvae that underwent metamorphosis, losing their transient larval structures, such as gills and tails (Fig. 3A, B). The loss of gills is evident by the slimming of the body profile in the pharyngeal region (arrow in A). The remnant of the tail is indicated by the arrow in B. Loss of these structures occurs via apoptosis during metamorphosis in response to thyroid hormone [42].
###end p 19
###begin p 20
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Metamorphosis of XR11 transgenic tadpoles and responses to exogenous thyroid hormone (T<sub>3</sub>)</bold>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 91 95 91 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic>, <italic>B</italic></bold>
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-J</italic>
###xml 150 153 150 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C-J</italic></bold>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 277 280 277 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-J</bold>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-F</italic>
###xml 361 364 361 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C-F</italic></bold>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 370 381 370 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E, G and I </italic>
###xml 370 381 370 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>E, G and I </italic></bold>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></bold>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 411 412 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>F</italic></bold>
###xml 414 416 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H </italic>
###xml 414 416 414 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>H </italic></bold>
###xml 420 422 420 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J </italic>
###xml 420 422 420 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J </italic></bold>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K-R</italic>
###xml 513 516 513 516 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K-R</italic></bold>
###xml 606 608 606 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K, M, O </italic>
###xml 673 681 673 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K, M, O </italic></bold>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q</italic>
###xml 685 686 685 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Q</italic></bold>
###xml 729 737 729 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L, N, P </italic>
###xml 729 737 729 737 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L, N, P </italic></bold>
###xml 741 742 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 741 742 741 742 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic></bold>
###xml 817 821 817 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M, N</bold>
###xml 862 864 862 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 875 876 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 875 876 875 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>S</italic></bold>
Metamorphosis of XR11 transgenic tadpoles and responses to exogenous thyroid hormone (T3). A, B. An XR11 transgenic froglet undergoing metamorphosis. C-J. Responses of one-week old (approximately stage 45) transgenic tadpoles to thyroid hormone (T3). XR11 transgenic tadpoles (G-J;) display the same gross responses to 5 days exposure to as do GFP transgenics (C-F). C, E, G and I are live tadpoles, whereas D, F, H and J are fixed tadpoles stained with Alcian blue to reveal the skeleton and the gill apparatus. K-R. The apoptotic response of one-week old transgenic tadpoles (approximately stage 45) to T3 was assessed in cross-sections through the velum. DAPI staining (K, M, O and Q) reveals nuclei, whereas the TUNEL assay (L, N, P and R) distinguishes apoptotic nuclei. The velum of the GFP transgenic tadpole (M, N) has begun dissociating in response to T3 treatment. S. Demonstration of XR11 over-expression in tadpoles by immunoprecipitation. This experiment was repeated once.
###end p 20
###begin p 21
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C&#8211;J</xref>
###xml 514 516 514 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 547 549 547 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 657 659 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F </italic>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
To address more specifically whether apoptosis can be triggered by thyroid hormone in XR11 transgenics, we used the metamorphosis induction assay described by Tata [43] and Huang et al. [44]. One-week tadpoles were exposed to triiodothyronine (T3) for five days. As shown in Figure 3C-J, tadpoles transgenic for XR11 displayed the same gross responses to thyroid hormone, including gill resorption, as shown by the GFP transgenics with no discernable delay. The gill apparatus, which is visible in the absence of T3 (arrow in H), regresses after T3 treatment in both cases. Meckel's cartilage (the lower jaw) shows a dramatic beak-like reshaping (arrows in F and J).
###end p 21
###begin p 22
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3K&#8211;R</xref>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3S</xref>
###xml 1096 1097 1096 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
To determine whether apoptosis was occurring equally in the GFP and XR11 transgenic tadpoles, we focused on the ventral velum, a portion of the larval filter feeding apparatus that has a chevron shape in cross section before it dissociates through apoptosis during metamorphosis [45]. As shown in Figure 3K-R, TUNEL-positive nuclei, which are rare in the velums in the absence of T3, were prevalent in the velums of both T3-treated GFP and XR11 transgenic tadpoles. These results indicate that apoptosis that occurred in response to thyroid hormone was unaffected by over-expression of XR11. One possible explanation for the extensive apoptosis in the XR11 transgenic tadpoles is that the XR11 protein was no longer over-expressed. However, as shown in Figure 3S, immunoblotting with an antibody to XR11 confirmed that the 22 kDa XR11 protein was over-expressed in the transgenic tadpoles. Proteins were extracted from individual tadpoles at approximately stage 45, separated by electrophoresis, blotted and probed as described in Methods. These tadpoles had been treated with triiodothyronine (T3). Similar results were obtained with samples from untreated tadpoles (data not shown). The variation in the GFP signal reflected the intensity of GFP fluorescence in the live tadpoles, presumably reflecting differences in the number of integrated copies of GFP. The 22 kDa XR11 signal is considerably stronger in the XR11 transgenic sample than in the GFP transgenic sample, reflecting XR11 transgene expression.
###end p 22
###begin title 23
XR11 transgenic frogs are fertile and transmit the transgene
###end title 23
###begin p 24
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The failure of XR11 over-expression to prevent metamorphosis enabled us to rear the resultant frogs to sexual maturity. We induced ovulation in adult females and used the sperm from adult males to obtain second-generation embryos overexpressing XR11. The results of representative crosses are shown in Table 1. Individual parents were designated by number (i.e., XR11-01, XR11-02). Crossing the XR11-01 male with a wild-type female gave a 1:1 ratio of transgene positive to transgene negative progeny, suggesting that his genome had integrated the transgene at a single site. Crossing him with the XR11-01 female gave a 3:1 ratio, a result consistent with a single transgene integration site. However, crossing him with the XR11-02 female yielded a 7:1 ratio, suggesting that this female had two transgene integration sites.
###end p 24
###begin p 25
Representative Crosses Illustrating Inheritance of the XR11 Transgene
###end p 25
###begin title 26
Over-expression of XR11 curtailed apoptosis induced by irradiation
###end title 26
###begin p 27
###xml 256 258 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 292 292 288 288 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1471-213X-5-20-i1.gif"/>
###xml 490 494 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;F</xref>
###xml 527 529 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 684 686 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
The ability to produce second-generation transgenics gave us the opportunity to compare the effects of maternal and zygotic expression of the XR11 transgene on susceptibility of embryos to gamma-radiation-induced apoptosis. Consistent with the literature [15], wild-type embryos subjected to -radiation before the MBT did not undergo apoptosis before the MBT (data not shown). The appearance of TUNEL-positive nuclei was delayed until after the MBT and was radiation dosage-dependent (Fig. 4A-F). After exposure to 10 Gy (Fig. 4B) blastopores were not evident, and large sectors containing TUNEL-positive nuclei were seen. More extensive damage was seen after exposure to 20 Gy (Fig. 4C). TUNEL-positive nuclei were pervasive. Dissociation of the embryos was so extensive that the embryos often fragmented during the TUNEL procedure.
###end p 27
###begin p 28
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Maternal and paternal expression of the XR11 transgene</bold>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-F</italic>
###xml 56 59 56 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-F</italic></bold>
###xml 257 260 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 257 260 253 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-C</italic></bold>
###xml 281 282 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 281 282 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 442 443 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 442 443 438 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 500 501 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 500 501 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 504 507 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D-F</italic>
###xml 504 507 500 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D-F</italic></bold>
###xml 614 615 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 614 615 610 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>E</italic></bold>
###xml 627 628 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 627 628 623 624 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>F</italic></bold>
###xml 708 711 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-L</italic>
###xml 708 711 704 707 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-L</italic></bold>
###xml 956 959 944 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-I</italic>
###xml 956 959 944 947 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-I</italic></bold>
###xml 1023 1026 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J-L</italic>
###xml 1023 1026 1011 1014 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J-L</italic></bold>
###xml 1092 1093 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1092 1093 1080 1081 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic></bold>
###xml 1095 1096 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 1095 1096 1083 1084 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J</italic></bold>
###xml 1108 1112 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H, K</italic>
###xml 1108 1112 1096 1100 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>H, K</italic></bold>
###xml 1121 1125 1109 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I, L</italic>
###xml 1121 1125 1109 1113 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>I, L</italic></bold>
Maternal and paternal expression of the XR11 transgene. A-F. Maternal expression of the XR11 transgene reduces the extent of apoptosis in embryos exposed to gamma-radiation at stage 6-6.5 and examined 12 hours after irradiation by whole-mount TUNEL assays. A-C, Wild-type embryos. A, Representative control embryos. Arrow indicates the blastopore lip. No evidence of apoptosis is apparent. Embryos that had been exposed to 10 Gy are shown in B. More extensive damage is seen after exposure to 20 Gy (C). D-F, TUNEL assays of progeny of fertilization of XR11 eggs by wild-type sperm after exposure to either 10 Gy (E) or 20 Gy (F). This experiment was conducted three times using eggs from four XR11 females. G-L. Paternal expression of the XR11 transgene does not protect embryos from apoptosis induced by gamma-radiation before the MBT. Representative whole-mount TUNEL assays comparing the effects of gamma-radiation at stage 6-6.5 on wild-type embryos (G-I) and progeny of fertilization of wild-type eggs by XR11 sperm (J-L). Embryos were fixed for TUNEL assay 12 hours after irradiation. G, J. Controls. H, K. 10 Gy. I, L. 20 Gy. This experiment was conducted twice using sperm from two XR11 males.
###end p 28
###begin p 29
###xml 197 202 193 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E, F</xref>
In contrast to the results with wild-type embryos, embryos produced by fertilization of eggs from XR11 females with wild-type sperm showed evidence of partial protection from gamma-radiation (Fig. 4E, F). Reduced damage from radiation was always observed after exposure to 10 Gy, but protection from 20 Gy was variable from experiment to experiment, suggesting that overexpression of XR11 was not always sufficient to overcome the effects of 20 Gy.
###end p 29
###begin p 30
###xml 587 591 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4J&#8211;L</xref>
###xml 600 604 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G&#8211;I</xref>
To investigate whether protection from radiation-induced damage was due to maternal or zygotic expression of the transgene, we irradiated embryos derived from fertilizing eggs of wild-type females with sperm from XR11 males and compared them to wild-type embryos. If zygotic expression of the transgene could partially overcome the effects of pre-MBT gamma-radiation, we would have expected to see a subset of embryos with few or no TUNEL-positive nuclei that resembled embryos derived from eggs of XR11 females. Instead, all embryos resembled irradiated wild-type embryos (compare Fig. 4J-L to Fig. 4G-I). Extensive TUNEL-positive nuclei are seen in both groups at both doses. Furthermore, the embryos exposed to 20 Gy fragmented during the TUNEL procedure. These results are consistent with a requirement for a maternal source of radiation protection at these early stages.
###end p 30
###begin p 31
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1180 1184 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A&#8211;F</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 1644 1652 1644 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5K, L, O</xref>
###xml 1657 1659 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5P</xref>
###xml 1770 1778 1770 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5M, N, Q</xref>
###xml 1783 1785 1783 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5R</xref>
According to the literature, embryos irradiated after the MBT do not undergo apoptosis [17,19,20]. Indeed, embryos that were irradiated after the MBT (stage 11.5) and examined 12 hours later did not show outward signs of radiation damage (data not shown). However, TUNEL assays showed that irradiation enhanced apoptosis in wild-type embryos, predominantly in the brain, eyes, pharynx and tail bud. Hence, we sought to determine whether the maternal effect of the XR11 transgene was sustained after the MBT and whether zygotic expression of the transgene could also confer radiation tolerance. To do this, we segregated the XR11 transgenic embryos of over-expressing XR11 females from their non-transgenic siblings based upon their expression of the GFP reporter gene under control of the cardiac actin promoter. The GFP negative (GFP-) embryos had maternal expression of the XR11 transgene but no zygotic expression, whereas the GFP positive (GFP+) embryos had both maternal and zygotic XR11 transgene expression. Results show that maternal expression of the XR11 transgene protected embryos irradiated at stage 11.5 even if they did not express zygotic XR11. As shown in Figure 5A-F, neither the GFP- nor the GFP+ embryos had extensive apoptosis after irradiation, although some GFP- embryos demonstrated some apoptosis in the hindbrain region, but not in the tail tip (see Fig. 5C). When embryos were irradiated during the mid-30 stages (late tail bud) and examined 12 hours later, the protection afforded by maternal expression of XR11 had diminished significantly in the head and pharynx, although the tail tips were still protected (Fig. 5K, L, O and 5P). However, zygotic expression of XR11 was very effective in conferring global protection from apoptosis (Fig. 5M, N, Q and 5R).
###end p 31
###begin p 32
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-F</italic>
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-R</italic>
###xml 0 214 0 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Representative TUNEL assays showing (<italic>A-F</italic>) the sustained radiation tolerance of early post-MBT embryos and (<italic>G-R</italic>) the effects of zygotic transgene expression in late post-MBT embryos derived from eggs of XR11 females</bold>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-F</italic>
###xml 217 220 217 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-F</italic></bold>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 303 306 303 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-C</italic></bold>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 359 360 359 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 371 372 371 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 381 382 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D-F</italic>
###xml 391 394 391 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D-F</italic></bold>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></bold>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 462 463 462 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>E</italic></bold>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 472 473 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>F</italic></bold>
###xml 557 560 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-R</italic>
###xml 557 560 557 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-R</italic></bold>
###xml 649 665 649 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G, H, K, L, O, P</italic>
###xml 649 665 649 665 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G, H, K, L, O, P</italic></bold>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G, H</italic>
###xml 718 722 718 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G, H</italic></bold>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K, L</italic>
###xml 825 829 825 829 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K, L</italic></bold>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O, P</italic>
###xml 838 842 838 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>O, P</italic></bold>
###xml 851 867 851 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I, J, M, N, Q, R</italic>
###xml 851 867 851 867 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>I, J, M, N, Q, R</italic></bold>
###xml 923 927 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I, J</italic>
###xml 923 927 923 927 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>I, J</italic></bold>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M, N</italic>
###xml 938 942 938 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>M, N</italic></bold>
###xml 979 981 979 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 979 981 979 981 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>M </italic></bold>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q, R</italic>
###xml 1018 1022 1018 1022 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Q, R</italic></bold>
Representative TUNEL assays showing (A-F) the sustained radiation tolerance of early post-MBT embryos and (G-R) the effects of zygotic transgene expression in late post-MBT embryos derived from eggs of XR11 females. (A-F). Embryos were irradiated at stage 11.5 and fixed for TUNEL assay 12 hours later. A-C. GFP-negative embryos (lacking the XR11 transgene). A, Control. B, 10 Gy. C, 20 Gy. D-F. GFP-positive embryos (containing the XR11 transgene). D, Control. E, 10 Gy. F, 20 Gy. This experiment was conducted four times using eggs from six XR11 females. G-R. Embryos were irradiated in the mid-30 stages and fixed for TUNEL assay 12 hours later. G, H, K, L, O, P. GFP-negative embryos (lacking the XR11 transgene). G, H. Control. Small numbers of TUNEL-positive nuclei are evidence of spontaneous developmental apoptosis. K, L. 10 Gy. O, P. 20 Gy. I, J, M, N, Q, R. GFP-positive embryos (containing the XR11 transgene). I, J. Control. M, N. 10 Gy. The ventral pigmentation in M is not due to TUNEL-positive nuclei. Q, R. 20 Gy. This experiment was conducted once using eggs from two XR11 females.
###end p 32
###begin p 33
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A&#8211;F</xref>
###xml 644 649 644 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C, F</xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G&#8211;L</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
###xml 1164 1169 1164 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H, I</xref>
To examine the effects of zygotic XR11 transgene expression in the absence of maternal expression, we irradiated stage 11.5 embryos derived from fertilizing eggs from wild-type females with sperm from XR11 males. Progeny were scored 12 hours later for GFP expression directed by the cardiac actin promoter to confirm the presence of the transgene. As shown in Figure 6A-F, there was extensive apoptosis in both the heads, pharynges and tail tips of irradiated neurula-stage embryos and no discernable difference in the levels of apoptosis observed between the GFP-positive and GFP-negative embryos. Embryos that received 20 Gy radiation (Figs. 6C, F) are stunted with blunt heads, indicative of extensive developmental defects. These results suggest that zygotic expression of the transgene had little effect in preventing apoptosis at this stage. However, when sibling embryos were irradiated in the mid-30 stages and examined 12 hours later, the transgene conferred global protection from apoptosis (Fig. 6G-L). Note particularly the extensive apoptosis that is evident in the otic capsules (arrows in Fig. 6H) of irradiated embryos lacking the transgene (Figs. 6H, I).
###end p 33
###begin p 34
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-F</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-L</italic>
###xml 0 200 0 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Representative TUNEL assays showing the effects of zygotic XR11 expression on radiation tolerance of (<italic>A-F</italic>) early post-MBT embryos and (<italic>G-L</italic>) late post-MBT embryos derived from eggs of wild-type females</bold>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-F</italic>
###xml 202 205 202 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-F</italic></bold>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 287 290 287 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-C</italic></bold>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 314 315 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 326 327 326 327 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 336 337 336 337 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D-F</italic>
###xml 346 349 346 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D-F</italic></bold>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></bold>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 417 418 417 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>E</italic></bold>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 427 428 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>F</italic></bold>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-L</italic>
###xml 513 516 513 516 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-L</italic></bold>
###xml 605 608 605 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-I</italic>
###xml 605 608 605 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-I</italic></bold>
###xml 632 633 632 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 644 645 644 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>H</italic></bold>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 654 655 654 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>I</italic></bold>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J-L</italic>
###xml 664 667 664 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J-L</italic></bold>
###xml 723 724 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 723 724 723 724 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J</italic></bold>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 735 736 735 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K</italic></bold>
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 745 746 745 746 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L</italic></bold>
Representative TUNEL assays showing the effects of zygotic XR11 expression on radiation tolerance of (A-F) early post-MBT embryos and (G-L) late post-MBT embryos derived from eggs of wild-type females. A-F. Embryos were irradiated at stage 11.5 and fixed for TUNEL assay 12 hours later. A-C. GFP-negative embryos. A. Control. B. 10 Gy. C. 20 Gy. D-F. GFP-positive embryos (containing the XR11 transgene). D. Control. E, 10 Gy. F. 20 Gy. This experiment was conducted three times using sperm from five XR11 males. G-L. Embryos were irradiated in the mid-30 stages and fixed for TUNEL assay 12 hours later. G-I. GFP-negative embryos. G. Control. H. 10 Gy. I. 20 Gy. J-L. GFP-positive embryos (containing the XR11 transgene). J. Control. K. 10 Gy. L. 20 Gy. This experiment was conducted once using sperm from two XR11 males. The experiment could not be repeated due to the unavailability of additional XR11 males.
###end p 34
###begin p 35
The TUNEL data presented above indicate that: (1) maternal expression of the XR11 transgene reduces the amount of apoptosis induced by gamma-radiation during pre-MBT and early post-MBT stages, (2) protection from apoptosis by maternal transgene expression is sustained in the tail tip after tissues in the head become susceptible to apoptosis (irradiation in the mid-30 stages) and (3) radiation tolerance is acquired gradually after the MBT and is sufficient to provide complete protection from apoptosis to embryos irradiated in the mid-30 stages of development.
###end p 35
###begin p 36
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
To correlate transgene expression with repression of radiation-induced apoptosis, we monitored XR11 RNA expression and protein levels (Fig. 7). Expression of XR11 at the RNA level in embryos was monitored by RT-PCR with primers designed against the XR11 sequence. RT-PCR was performed on first strand cDNA synthesized from RNA isolated from pre-MBT (stage 7) and post MBT (stage 10.5 and mid-30 stages) wild-type embryos and embryos derived from fertilizing eggs of two different XR11 females with wild-type sperm and the fertilization of wild-type eggs with XR11 sperm. As shown in Figure 7A, we observed maternal XR11 transcripts in pre-MBT embryos derived from transgenic females. On the contrary, there was no evidence for expression of the XR11 transgene in embryos derived from wild-type eggs fertilized by XR11 sperm. After the MBT, XR11 mRNA derived from both maternal and paternal transgenes was evident. Immunoblots (Fig. 7B) indicated the presence of maternally-derived XR11 protein and the accumulation of XR11 protein from either maternal or paternal transgene expression after the MBT.
###end p 36
###begin p 37
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Maternal and zygotic XR11 RNA expression and protein levels</bold>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 258 259 254 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
Maternal and zygotic XR11 RNA expression and protein levels. A. Over-expression of XR11 at the RNA level. RT-PCR of the constitutively expressed elongation factor 1-alpha (EF1alpha) was conducted in parallel as a control. This experiment was conducted once. B. XR11 protein levels in pre- and post-MBT embryos were demonstrated by Western blot analysis. Because the XR11 protein is membrane-bound, it is difficult to separate it from yolk, which is abundant in embryos. The presence of yolk during electrophoresis results in wavy bands in the gel. This experiment was repeated once.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 236 238 236 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 522 524 518 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
The application of technology to modify Xenopus genetically has created opportunities to conduct functional analyses that are not readily achieved by other means. In this study, we have used XR11 transgenics to examine the role of Bcl-xL in suppressing apoptosis during embryonic development, thyroid-hormone-induced metamorphosis and in response to gamma-radiation. Our ability to raise XR11 transgenic frogs to maturity has also given us the opportunity to distinguish between maternal and zygotic contributions of Bcl-xL to radiation protection.
###end p 39
###begin p 40
###xml 69 71 69 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 247 255 247 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 467 469 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1012 1014 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1058 1064 1058 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-2 </italic>
###xml 1114 1122 1114 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 126 133 <span type="species:ncbi:9031">chicken</span>
###xml 1052 1057 <span type="species:ncbi:9606">human</span>
This study supports the growing evidence in the literature that Bcl-xL is sufficient to promote neuronal survival in mice and chicken embryos [32-35]. Our experiments showed that the XR11 transgene could eliminate most apoptosis in the developing Xenopus nervous system, including the brain and eyes. This result is consistent with a model in which the execution of developmental apoptosis is dependent upon a balance between pro-and anti-apoptotic factors with Bcl-xL being one of the anti-apoptotic factors. In spite of the abatement of developmental apoptosis in XR11 transgenic embryos, there were no apparent gross developmental consequences; the embryos developed into phenotypically normal tadpoles. This result suggests that developmental apoptosis is not essential for development of vital organ systems, notably the central nervous system, and that embryos can adapt to an overabundance of neurons. However, detailed morphometric studies would be necessary to confirm this conclusion. Yeo and Gautier [39] previously showed that injection of human bcl-2 mRNA abrogated programmed cell death during early Xenopus development, resulting in an expansion of neural tissue and variations in the patterns of expression of a number of genes expressed during early neurogenesis. We did not examine gene expression patterns in our embryos. However, if such alterations did occur, they had no apparent functional consequences.
###end p 40
###begin p 41
###xml 156 158 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 936 943 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
Contrary to expectation, metamorphosis of XR11 transgenic tadpoles was normal, as was the response to exogenous thyroid hormone. If over-expression of Bcl-xL had hindered metamorphosis, it would have indicated that thyroid hormone triggers apoptosis by shifting the balance between pro-apoptotic factors and Bcl-xL. However, this proved not to be the case, even though we found that Bcl-xL was still misexpressed at metamorphosis. One possibility is that other members of the Bcl-2 family counter apoptosis during these later stages. Another possibility for the failure of XR11 transgenesis to prevent apoptosis during metamorphosis is that expression of the transgene was insufficient to shift the balance between pro-and anti-apoptotic factors sufficiently to prevent apoptosis. It is also possible that subtle changes in the timing, rate or cellular selectivity of metamorphosis did occur that we failed to detect. For example, Coen et al. [41] demonstrated selective protection of Rohon-Beard neurons in XR11 over-expressing tadpoles during metamorphosis. We did not assess cell-specific neoronal survival during metamorphosis.
###end p 41
###begin p 42
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 409 411 409 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 732 738 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bcl-2 </italic>
###xml 748 756 744 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 822 824 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 726 731 <span type="species:ncbi:9606">human</span>
Upon reaching sexual maturity, both male and female frogs were fertile. Crosses of transgenic frogs indicated that most had small numbers of transgene integration sites. This result was consistent with a previous transgene transmission study [46]. The ability to produce second generation transgenic XR11 embryos provided us with the opportunity to examine both the maternal and zygotic contributions of Bcl-xL to the apoptotic response to gamma-radiation. This provided evidence for a significant role for apoptotic factor balance in determining whether cells that had received damaging dosages of radiation during development were eliminated. Other Bcl-2 family members may carry out similar roles in that microinjection of human Bcl-2 mRNA into Xenopus embryos is effective in inhibiting irradiation-induced apoptosis [16].
###end p 42
###begin p 43
###xml 282 284 282 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 669 671 669 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 707 709 707 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Expression of the XR11 transgene had a profound effect on whether cells of irradiated embryos underwent apoptosis. Furthermore, the application of transgenics allowed us to demonstrate that this effect depended upon the source of the over-expressed protein. Over-expression of Bcl-xL derived from XR11 females provided partial protection from the normal massive apoptosis that occurs in irradiated pre-MBT wild-type embryos after reaching the MBT. However, if the XR11 gene was derived from XR11 males, no protection was seen. This result demonstrates conclusively that apoptosis triggered by irradiation before the MBT can be restrained by maternal expression of Bcl-xL and that zygotic expression of Bcl-xL is ineffective in overcoming the effects of prior irradiation.
###end p 43
###begin p 44
Irradiation soon after the MBT (at stage 11.5) had much more subtle effects on embryos. In wild-type embryos, apoptosis was enhanced in the brain, eyes, pharynx and tail tip. However, maternal expression of XR11 was sufficient to abrogate apoptosis. Interestingly, zygotic expression of XR11 at this time was not effective in preventing apoptosis even though XR11 protein was abundant at the time of irradiation. The failure of zygotically-derived XR11 to provide protection from apoptosis implies that synthesis of XR11 protein is not sufficient to prevent apoptosis.
###end p 44
###begin p 45
###xml 467 469 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Embryos irradiated during the mid-30 stages of development revealed that the maternal effect conferring protection from radiation-induced apoptosis had diminished significantly in the head and pharynx but persisted in the tails. It will be interesting to learn whether the difference between the heads and tails is due to preferential distribution or stability of maternal XR11 protein itself or is due to auxiliary factors that influence XR11 protein function. Bcl-xL and other members of the Bcl-2 family are known to be subject to post-translational regulation by such events as phosphorylation, proteolysis, cleavage, protein-protein interactions and subcellular localization [47,48]. Intriguingly, at these later stages, zygotic XR11 protein conferred global radiation protection. Thus, the initial lack of functionality of zygotic XR11 protein that we observed after the MBT had been overcome.
###end p 45
###begin p 46
###xml 812 818 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-2 </italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bcl-x</italic>
###xml 826 828 826 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 826 828 826 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L </italic></sub>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Biologically, the responses to irradiation after the MBT are probably more significant than the universal, catastrophic apoptosis that occurs in embryos irradiated before the MBT. Failure to eliminate cells mutagenized by irradiation would result in retention of cells that may have functional deficiencies and have the potential to become malignant due to genetic damage. Thus, the mechanisms that control apoptosis in response to DNA damage have important adaptive significance. Radiotherapy and a number of chemicals have been shown to damage DNA and induce apoptosis in mammals; this property has been exploited in the clinic to induce apoptosis of cancer cells. Resistance to apoptosis has important implications for the efficacy of chemotherapy and radiotherapy because tumor cells that overexpress either bcl-2 or bcl-xL may be resistant to either mode of cancer therapy [37,49-52]. On the other hand, their over-expression in non-tumor cells could enhance the ability of these cells to survive the otherwise lethal effects of radiation and chemotherapy.
###end p 46
###begin p 47
###xml 44 46 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 187 189 187 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 481 483 481 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Our results indicate that synthesis of Bcl-xL is not sufficient to confer radiation protection; rather, it belatedly acquires functionality. Possible explanations for the failure of Bcl-xL synthesized after the MBT to protect against apoptosis could include the absence of posttranslational modifications to the protein or the lack of a cooperative factor that is necessary for the protein to function effectively. The presence of this mechanism that confers functionality on Bcl-xL protein before the MBT and its absence soon after the MBT may provide an assay system that would facilitate its identification. The discovery of a mechanism that could control whether cells undergo apoptosis after exposure to an apoptogenic stimulus could have important implications for improving the efficacy of chemotherapy and radiotherapy.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 178 180 178 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 573 575 573 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 735 736 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 774 776 770 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Our results are consistent with a model in which the execution of developmental apoptosis in embryos is dependent upon a balance between pro-and anti-apoptotic factors with Bcl-xL being one of the anti-apoptotic factors. The drastic reduction of apoptosis in XR11 transgenic embryos had no apparent functional consequences. Metamorphosis of transgenic tadpoles was apparently normal, as was the response to exogenous thyroid hormone. The ability to produce second-generation transgenic XR11 embryos enabled us to examine both the maternal and zygotic contributions of Bcl-xL to the apoptotic response to gamma-radiation. Post-MBT apoptosis that was triggered by irradiation before the MBT was restrained by maternal expression of Bcl-xL. However, zygotic expression of Bcl-xL was ineffective in overcoming the effects of prior irradiation. Maternal expression of XR11 was also sufficient to abrogate apoptosis triggered by post-MBT gamma-radiation. However, zygotic expression of XR11 at this time was not effective in preventing apoptosis even though XR11 protein was abundant.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
Transgenesis
###end title 51
###begin p 52
###xml 6 21 6 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 632 634 632 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 6 20 <span type="species:ncbi:8355">Xenopus laevis</span>
Adult Xenopus laevis were maintained in compliance with the University of Calgary guidelines for animal care. Our transgenesis protocol is based upon the technique described by Sparrow[53], which is a simplification of the procedure described by Kroll and Amaya [40]. The simplified technique eliminates the need to use egg extract and restriction enzyme to facilitate transgenesis. We have found no significant difference in the frequencies of either normal development, transgenesis or viability of embryos, tadpoles or frogs using these two techniques (data not shown). The simplified transgenic reaction involves mixing 2.5 x 105 nuclei in 2.5 mul of sperm storage buffer, 100 ng linearized DNA in 2.5 mul of water. The components are mixed and left for 10 minutes at room temperature (~20-23degreesC). At this point, 495 mul of sperm dilution buffer is added, and the suspension is mixed gently and thoroughly before loading into microinjection needles for nuclear transplantation. Nuclear transplant embryos were screened for expression of the transgene by detecting GFP fluorescence using an Olympus SZX9 fluorescent stereomicroscope.
###end p 52
###begin title 53
Tadpole husbandry
###end title 53
###begin p 54
Tadpoles were fed Sera Micron , which is a fine granulated tropical fish food. This proved to be an excellent diet for tadpoles, which were maintained on it until metamorphosis. After metamorphosis, froglets were fed progressively larger forms of NASCO Frog Brittle. Tadpoles were either maintained in plastic food containers in which water was changed manually as needed or in continuously circulating Z-MOD tanks (Marine Biotech, Beverly, MA). After metamorphosis, frogs were maintained in Z-MOD tanks until they became large enough to be transferred to larger-sized X-MOD tanks.
###end p 54
###begin title 55
RNA purification
###end title 55
###begin p 56
Whole tadpoles were homogenized in 100 mul TRIZOL (Invitrogen), and 400mul of the reagent were added to the homogenate. After incubation for 5 min at room temperature, 100mul of chloroform were added, the mixture was shaken vigorously for 15 seconds, incubated for 2-3 minutes at room temperature and centrifuged at 12,000 x g for 15 minutes at 4degreesC. 250 mul of isopropanol were added to the supernatant, which was then incubated for 10 minutes at room temperature and centrifuged at 12,000 x g for 10 minutes at 4degreesC. The supernatant was removed, and 500 mul of 75% ethanol were added to the pellet. After mixing well, the mixture was centrifuged at 7,500 x g for 5 minutes at 4degreesC. The supernatant was discarded, and the pellet was air-dried. The dried pellet was rehydrated in RNase-free water and stored at -80degreesC. Any contaminating DNA was removed with DNA-free (Ambion) according to the manufacturer's protocol. RNA concentration was determined by spectrophotometry at 260 nm.
###end p 56
###begin title 57
RT-PCR
###end title 57
###begin p 58
Ready-to-Go RT-PCR beads (Amersham Pharmacia) were used according to the manufacturer's instructions for one-step reactions. RT-PCR reactions for XR11 and EF1alpha were run in tandem. 500 ng total RNA and 10 pmoles XR11 primers or 5 pmoles EF1alpha primers were used in each 50 ml reaction. The first strand reaction ran for 15 minutes followed by a 5 minute incubation at 95degreesC The PCR step ran for 35 cycles for the XR11 product or 30 cycles for the EF1alpha product. Each cycle was 94degreesC for 1 minute, followed by 55degreesC for 1 minute and 72degreesC for 1 minute. The reaction was stopped by reducing the temperature to 4degreesC. If necessary, the reaction products could be stored at -20degreesC until analyzed. The PCR products were analyzed by applying 10 mul samples to a 1.5%agarose/TAE gel containing 0.25 mug ethidium bromide (Sigma-Aldrich) in parallel with a 100 bp ladder (Amersham Pharmacia).
###end p 58
###begin p 59
EF1alpha-downstream primer: ACTGCCTTGATGACTCCTAG
###end p 59
###begin p 60
EF1alpha-upstream primer: CAGATTGGTGCTGGATATGC
###end p 60
###begin p 61
This primer pair will generate a 270 bp band.
###end p 61
###begin p 62
XR11-downstream primer: GGCATTCTTTCCATACAGGC
###end p 62
###begin p 63
XR11-upstream primer: CCTTCTACTTCAGAGCGCCC
###end p 63
###begin p 64
This primer pair will generate a 400 bp band.
###end p 64
###begin title 65
Immunoblotting
###end title 65
###begin p 66
###xml 92 98 <span type="species:ncbi:9986">rabbit</span>
###xml 279 283 <span type="species:ncbi:9925">goat</span>
###xml 289 295 <span type="species:ncbi:9986">rabbit</span>
Antiserum to XR11 was prepared by Alpha Diagnostics International, Inc. (San Antonio TX) in rabbit against a synthetic peptide encompassing amino acids 11-30 (KFV SKK LSQ NEA CRK FSN NP). This antiserum was used for immunoblotting at a dilution of 1:1000. Secondary antibody was goat anti-rabbit conjugated to alkaline phosphatase (Jackson ImmunoResearch), which was used at a dilution of 1:1000.
###end p 66
###begin p 67
Individual embryos were homogenized so as to correlate immunoblot results with GFP expression levels. Proteins in tissue homogenates were separated using 15% SDS-polyacrylamide gel electrophoresis and blotted onto PVDF. Blots were blocked either overnight at 4degreesC or for 1.5 hours at room temperature in 5% skim milk powder in TBS containing 0.1% Tween 20. The blots were then incubated with the primary antibody in TBS containing 0.1% Tween 20 for 1 to 2.5 hr at room temperature, washed 1 x 15 min and 3 x 5 min in TBS containing 0.1%Tween 20. The blots were then incubated with the conjugated secondary antibody in TBS containing 0.1% Tween 20 for 1 hr at room temperature, washed as described above, rinsed with TBS, then with staining buffer without stain reagents, followed by staining with NBT/BCIP until developed.
###end p 67
###begin title 68
Embryo whole-mount TUNEL assays
###end title 68
###begin p 69
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 473 474 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 475 477 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Pigmented embryos were collected at stages 28, 33, 37, and 41 and processed for TUNEL assays as described by Hensey and Gautier [13]. After staining, the embryos were fixed while rocking overnight at room temperature in Bouin's solution (70 ml water, 25 ml 37% formaldehyde, 5 ml glacial acetic acid). Embryos were then washed (four times for 15 minutes each) in TE buffered ethanol. Embryos were then bleached for 1 hour at room temperature in 0.5 x SSC, 5% formamide, 1%H2O2 in a Petri dish on a piece of aluminum foil on a shaker under a fluorescent lamp, washed twice for 5 min each in methanol and cleared in BB/BA (2:1 benzylbenzoate:benzyl alcohol). Photographs were taken of embryos representative of the extremes of TUNEL-positive nuclei.
###end p 69
###begin title 70
Cryosectioning
###end title 70
###begin p 71
###xml 131 132 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 515 523 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 210 213 <span type="species:ncbi:9685">Cat</span>
Samples were collected at the appropriate stages and fixed overnight at 4degreesC in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7 % formaldehyde). Samples were then embedded in OCT Compound (Tissue Tek Cat #4583). The embedded samples could then either be stored at -80degreesC or sectioned immediately. 14 mum sections were made using a Microm cryostat with cabin temperature set at -12degreesC. Sections were stored at -20degreesC if not processed immediately. Sections were processed using the ApoTagRed in situ Apoptosis Detection Kit, catalogue #7165 according to the manufacturer's protocol (Intergen Co., Purchase NY). Sections were visualized using a Zeiss Axioplan 2 microscope with Spot camera and software.
###end p 71
###begin title 72
Induced metamorphosis
###end title 72
###begin p 73
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 38 41 <span type="species:ncbi:9685">Cat</span>
3,3',5-Triiodo-L-thyronine (T3; Sigma Cat #T2752) was added one week after fertilization to a final concentration of 10 nM to tadpole water and changed daily for the duration of the experiment [44](Huang et al., 1999). Before and during treatment, tadpoles were maintained in 0.1 x MMR (for description, see Kroll and Amaya [40]) in the absence of food. Tadpoles responded uniformly to the hormone.
###end p 73
###begin title 74
Cartilage staining
###end title 74
###begin p 75
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
Cartilage was visualized in tadpoles according to the procedure described by Klymkowsky and Hanken [54]. Tadpoles were anesthetized in 0.02% benzocaine and immersed in 0.02% Alcian blue 8GX in 70% ethanol/30% glacial acetic acid. After staining, tadpoles were passed through an ethanol series (100, 100, 95, 70, 40, 15%) and then into distilled water. They were then washed in two changes of methanol and cleared in BB/BA.
###end p 75
###begin title 76
Irradiation of embryos
###end title 76
###begin p 77
Embryos to be irradiated were placed in ~2.5 ml 0.1 x MMR in 35 x 10 mm plastic Petri dishes (approx. 20/dish) and exposed to either 10 Gy or 20 Gy from a Cesium 137 source in a Gammacell 1000 irradiation chamber (MDS Nordion International Inc., Ottawa, ON Canada). After irradiation, embryos were transferred to 60 x 10 mm plastic Petri dishes containing 0.1 x MMR and allowed to recover for 12 hours at room temperature. Unless noted otherwise, each experiment was repeated at least once.
###end p 77
###begin title 78
List of abbreviations
###end title 78
###begin p 79
DAPI: 4',6-diamidino-2-phenylindole dihydrochloride
###end p 79
###begin p 80
GFP: green fluorescent protein
###end p 80
###begin p 81
MBT: Mid-blastula transition
###end p 81
###begin p 82
NBT: Nitroblue tetrazolium
###end p 82
###begin p 83
PCD: programmed cell death
###end p 83
###begin p 84
SSC: sodium chloride/sodium citrate
###end p 84
###begin p 85
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
T3: 3,3',5-triiodothyronine
###end p 85
###begin p 86
TBS: Tris-buffered saline
###end p 86
###begin p 87
TAE: 40 mM Tris-acetate and 1 mM EDTA
###end p 87
###begin p 88
TE: 10 mM Tris-HCl and 1 mM EDTA
###end p 88
###begin p 89
TUNEL: TdT-mediated dUTP digoxigenin nick end labeling
###end p 89
###begin title 90
Authors' contributions
###end title 90
###begin p 91
JJ conducted the transgenesis experiments, the molecular studies, the thyroid hormone experiments, the irradiation experiments and helped to draft the manuscript. RC assisted in perfecting the transgenesis technique and conducted the experiments on developmental apoptosis. MC-S initiated the radiation experiments. SM participated in the design of the study and helped draft the manuscript. LWB conceived of the study and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 91
###begin title 92
Supplementary Material
###end title 92
###begin title 93
Additional File 1
###end title 93
###begin p 94
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Figure 2
###end p 94
###begin p 95
Click here for file
###end p 95
###begin title 96
Acknowledgements
###end title 96
###begin p 97
###xml 171 174 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 179 183 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 188 191 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Supported by grants to LWB and SMcF from the Natural Sciences and Engineering Research Council of Canada and to LWB from the Alberta Cancer Board. Plasmids containing the CMV-GFP-SV40 and CMV cassettes for construction of the plasmid containing co-linear CMVXR11 and CARGFP genes were generous gifts from Dr. Enrique Amaya. Dr. James Maller generously supplied the XR11 gene, which was originally cloned by Cruz-Reyes and Tata.
###end p 97
###begin article-title 98
How death shapes life during development
###end article-title 98
###begin article-title 99
Cell death in normal vertebrate ontogeny
###end article-title 99
###begin article-title 100
Programmed cell death in development
###end article-title 100
###begin article-title 101
Programmed Cell Death--I. Cytology Of Degeneration In The Intersegmental Muscles Of The Pernyi Silkmoth
###end article-title 101
###begin article-title 102
Mechanisms and functions of cell death
###end article-title 102
###begin article-title 103
Programmed cell death in animal development
###end article-title 103
###begin article-title 104
Mechanisms of programmed cell death in the developing brain
###end article-title 104
###begin article-title 105
Regressive events in neurogenesis
###end article-title 105
###begin article-title 106
Programmed cell death in the developing nervous system
###end article-title 106
###begin article-title 107
Cell death during development of the nervous system
###end article-title 107
###begin article-title 108
Cell death in cortical development: How much? Why? So what?
###end article-title 108
###begin article-title 109
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
###end article-title 109
###begin article-title 110
Programmed cell death during Xenopus development: a spatio-temporal analysis
###end article-title 110
###begin article-title 111
###xml 27 41 <span type="species:ncbi:8355">Xenopus laevis</span>
Expression and function of Xenopus laevis p75(NTR) suggest evolution of developmental regulatory mechanisms
###end article-title 111
###begin article-title 112
Ionizing radiation induces apoptosis and elevates cyclin A1-Cdk2 activity before but not after the midblastula transition in Xenopus
###end article-title 112
###begin article-title 113
A developmental timer that regulates apoptosis at the onset of gastrulation
###end article-title 113
###begin article-title 114
Zygotic transcription is required to block a maternal program of apoptosis in Xenopus embryos
###end article-title 114
###begin article-title 115
Developmentally regulated activation of apoptosis early in Xenopus gastrulation results in cyclin A degradation during interphase of the cell cycle
###end article-title 115
###begin article-title 116
The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage
###end article-title 116
###begin article-title 117
Responses to DNA damage in Xenopus: cell death or cell cycle arrest
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ICE/CED-3 protease nomenclature
###end article-title 118
###begin article-title 119
Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases
###end article-title 119
###begin article-title 120
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?
###end article-title 120
###begin article-title 121
The pathophysiology of mitochondrial cell death
###end article-title 121
###begin article-title 122
Life-or-death decisions by the Bcl-2 protein family
###end article-title 122
###begin article-title 123
The Bcl2 family: regulators of the cellular life-or-death switch
###end article-title 123
###begin article-title 124
New members of the Bcl-2 family and their protein partners
###end article-title 124
###begin article-title 125
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
###end article-title 125
###begin article-title 126
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice
###end article-title 126
###begin article-title 127
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
###end article-title 127
###begin article-title 128
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
###end article-title 128
###begin article-title 129
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death
###end article-title 129
###begin article-title 130
Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
###end article-title 130
###begin article-title 131
Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival
###end article-title 131
###begin article-title 132
Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors
###end article-title 132
###begin article-title 133
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
###end article-title 133
###begin article-title 134
###xml 70 85 <span type="species:ncbi:10090">transgenic mice</span>
Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation
###end article-title 134
###begin article-title 135
Cloning, characterization and expression of two Xenopus bcl-2-like cell-survival genes
###end article-title 135
###begin article-title 136
A role for programmed cell death during early neurogenesis in xenopus
###end article-title 136
###begin article-title 137
Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation
###end article-title 137
###begin article-title 138
Xenopus Bcl-XL selectively protects Rohon-Beard neurons from metamorphic degeneration
###end article-title 138
###begin article-title 139
Gene expression during metamorphosis: an ideal model for post-embryonic development
###end article-title 139
###begin article-title 140
Early metamorphic competence of Xenopus larvae
###end article-title 140
###begin article-title 141
###xml 41 55 <span type="species:ncbi:8355">Xenopus laevis</span>
Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase
###end article-title 141
###begin article-title 142
###xml 52 66 <span type="species:ncbi:8355">Xenopus laevis</span>
Regression of blood vessels in the ventral velum of Xenopus laevis Daudin during metamorphosis: light microscopic and transmission electron microscopic study
###end article-title 142
###begin article-title 143
###xml 40 54 <span type="species:ncbi:8355">Xenopus laevis</span>
Germ-line transmission of transgenes in Xenopus laevis
###end article-title 143
###begin article-title 144
All along the watchtower: on the regulation of apoptosis regulators
###end article-title 144
###begin article-title 145
VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli
###end article-title 145
###begin article-title 146
Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death
###end article-title 146
###begin article-title 147
Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
###end article-title 147
###begin article-title 148
Chemotherapy response and resistance
###end article-title 148
###begin article-title 149
###xml 47 53 <span type="species:ncbi:10090">murine</span>
Genetic analysis of chemoresistance in primary murine lymphomas
###end article-title 149
###begin article-title 150
A simplified method of generating transgenic Xenopus
###end article-title 150
###begin article-title 151
Whole-mount staining of Xenopus and other vertebrates
###end article-title 151

